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Abstract
Background: Artificial transcription factors (ATFs) are composed of DNA-binding and functional
domains. These domains can be fused together to create proteins that can bind a chosen DNA
sequence. To construct a valid ATF, it is necessary to design suitable DNA-binding and functional
domains. The Cys2-His2 zinc finger motif is the ideal structural scaffold on which to construct a
sequence-specific protein. A20 is a cytoplasmic zinc finger protein that inhibits nuclear factor
kappa-B activity and tumor necrosis factor (TNF)-mediated programmed cell death. A20 has been
shown to prevent TNF-induced cytotoxicity in a variety of cell types including fibroblasts, B
lymphocytes, WEHI 164 cells, NIH 3T3 cells and endothelial cells.
Results: In order to design a zinc finger protein (ZFP) structural domain that binds specific target
sequences in the A20 gene promoter region, the structure and sequence composition of this
promoter were analyzed by bioinformatics methods. The target sequences in the A20 promoter
were submitted to the on-line ZF Tools server of the Barbas Laboratory, Scripps Research Institute
(TSRI), to obtain a specific 18 bp target sequence and also the amino acid sequence of a ZFP that
would bind to it. Sequence characterization and structural modeling of the predicted ZFP were
performed by bioinformatics methods. The optimized DNA sequence of this artificial ZFP was
recombined into the eukaryotic expression vector pIRES2-EGFP to construct pIRES2-EGFP/ZFP-
flag recombinants, and the expression and biological activity of the ZFP were analyzed by RT-PCR,
western blotting and EMSA, respectively. The ZFP was designed successfully and exhibited
biological activity.
Conclusion: It is feasible to design specific zinc finger proteins by bioinformatics methods.
Background
In nature, gene expression is regulated at the transcrip-
tional level primarily by transcription factors that bind to
DNA. Many of these transcription factors consist of two
essential yet separable modules: a DNA-binding domain
and a functional domain [1-3]. Artificial transcription fac-
tors (ATFs) are composed of DNA-binding and functional
domains [4-6], which can be fused together to create pro-
teins that bind a chosen DNA sequence and regulate
expression of a specific gene in vivo [1,2,4,7,8]. Construc-
tion of ATFs in vitro includes construction of DNA-bind-
ing and function domains by various methods. It is very
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important to design a DNA-binding domain that recog-
nizes a specific DNA sequence. Recently there has been a
great deal of progress in the development of modular pro-
tein domains that recognize specific DNA triplets. The
Cys2-His2 zinc finger motif is the ideal structural scaffold
on which a sequence-specific protein may be constructed
[7,9]. DNA structural domains of zinc finger proteins
(ZFPs) usually consist of 3 or 6 zinc fingers. Artificial ZFP
(AZP) technology allows DNA sequences to be selected
directionally and a DNA-binding domain to be designed
[10-13].
A20 (Tumor Necrosis Factor Alpha-Induced Protein 3,
TNFAIP3) is a cytoplasmic zinc finger protein that inhibits
nuclear factor kappa-B (NFκB) activity and tumor necrosis
factor (TNF)-mediated programmed cell death [14-16].
A20 has been shown to prevent TNF-induced cytotoxicity
in a variety of cell types including fibroblasts, B-lym-
phocytes, WEHI 164 cells, NIH 3T3 cells and endothelial
cells [17]. Over-expression of A20 inhibits IL-1β-induced
production of NO by rat islets, which impacts positively
on islet graft survival and function [18]. Indeed, A20-defi-
cient cells fail to terminate TNF-induced NF-κB activation
[19]. Lee et al. generated A20-deficient mice by targeted
disruption. A20 -/- mice, born from interbred A20 +/-
mice in Mendelian ratios, developed runting as early as 1
week of age [13]. Mice deficient in A20 developed severe
inflammation and cachexia, were hypersensitive to both
lipopolysaccharide and TNF, and died prematurely.
In the present study, to provide a basis for designing ATFs
that can regulate the human A20 gene, a ZFP sequence
involving six contiguous Cys2His2-type zinc fingers was
constructed using the classical Cys2His2-type zinc finger
model and an 18 bp DNA sequence (as target sequence)
obtained from the A20 gene promoter region.
Results
Transcription start site and presumptive promoter 
sequence of A20 gene
The DNA sequence of the human A20 gene (-1000 bp –
+300 bp) was used to analyze the promoter region. Trans-
acting factors and related elements that may interact with
the aforementioned sequence were analyzed by the online
TFSEARCH[20], TESS[21] and Gene2Promoter serv-
ers[22]. The results indicated many trans-acting factors
binding the relevant elements in the gene sequence, with
several HSF binding sites at the distal end and 6 SP1 and
2 NF-κB binding sites in the GC-rich region at the proxi-
mal end.
The 1300 bp sequence was submitted to Gene2Promoter
of Genomatix[22] to locate the A20 gene TSS. The results
indicated 12 sequence fragments that may contain TSS
sites. The features of these sequence fragments were com-
pared with nucleic acid sequences of different histological
origins, and the score of a 121 bp sequence within
NC_000006 138229984 -138230104 of the genome
proved significantly higher than that of the other
sequence fragments. Hence, this 121 bp sequence proba-
bly includes the TSS of the A20 gene. Further analysis of
the 121 bp sequence showed that the score of the site in
genomic NC_000006 138230088 (the site in the
frame...agactgcgcagtctg..., see Seq.1) reached a peak (Fig.
1A). Therefore, the TSS of the A20 gene can be determined
by bioinformatics methods. The results of prediction were
consistent with the conclusions that Krikos drew from an
S1 Nuclease Protection Assay [23].
After the TSS of the A20 gene was determined, the estab-
lished promoter sequence of this gene was submitted to
Gene2Promoter of the Genomatix[22] and McPro-
moter[24] online server (Nuremberg University) to ana-
lyze the presumptive promoter sequence further. The
results suggested that the presumptive promoter might be
located within genomic NC_000006 138229781-
138230472 and be 692 bp in length. Moreover, analysis
by the McPromoter program based on a Markov model
suggested that the presumptive promoter may be a
sequence approximately 300 bp in length, which is cov-
ered by the sequence predicted by Gene2Promoter (Fig.
1B).
These analyses defined the presumptive promoter
sequence and TSS of the A20 gene. In the light of the fol-
lowing study design, a 396 bp sequence fragment within
NC_000006 138229786 -138230182 of the A20 gene
promoter was selected as the target sequence for study (see
Seq.1).
cttccgaaatgcccaggtgactcacgcggggacaccccggggcggggcgagggag
tttctccgggcgcctgcagggaccgggcggggcggggcagcggggcggggcag-
ggaaagggggcggggcggggcccgcaggcccggtcgggcggag-
gccgcgcgcgcccctcgccccctgcgccctctggcggccggctggacgcacttcgca
gcccgacccagagagtcacgtgactttggaaagtcccgtggaaatccccgggcct-
acaacccgcatacaactgaaacggggcaaagcagactgcgcagtctgcagtct-
tcgtggcgggccaagcgagcttggagcccgcgggggcggagcggtgagagcggc
cgccaagagagatcacacccccagcc (396 bp)
Procurement of target sequence of A20 gene promoter 
region and ZFP design
The presumptive promoter sequence obtained for the A20
gene was submitted to the ZF tools server [25] to "Search
DNA Sequence for Contiguous Target Sites". After setting
parameters and comparing with the characteristics of
ZFPs, we obtained an 18 bp DNA sequence 5'-cggccggct-
ggacgcact-3' (see the sequence in the frame in Seq. 1),
which was considered to be the target sequence interact-
ing with the artificial ZFP. This target sequence was then
submitted to "Design a Zinc Finger Protein". After settingBMC Biotechnology 2008, 8:28 http://www.biomedcentral.com/1472-6750/8/28
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parameters, we obtained the full-length amino acid
sequence of the ZFP (see Seq. 2), which comprised 176
amino acids. In the sequence, the gray bold letters sepa-
rately refer to the -1, +3 and +6 sites in the α-helix of the
zinc finger.
LEPGEKP YKCPECGKSFSTHLDLIRHQRTH
TGEKP YKCPECGKSFSHTGHLLEHQRTH
TGEKP YKCPECGKSFSQRAHLERHQRTH
A: The abscissa represents the region most probably containing the TSS, and the ordinate represents the score for each site Figure 1
A: The abscissa represents the region most probably containing the TSS, and the ordinate represents the 
score for each site. The higher the score, the more likely the site is to be the TSS. Analysis of the 121 bp sequence showed 
that the score of a site (located in the genomic NC_000006 138230088) reached a peak value (indicated by arrow). This site 
was probably the TSS of the A20 gene. B: Analysis by McPromoter based on a Markov model suggested that the presumptive 
promoter of the A20 gene might be located within the genomic NC_000006 138229786 -138230182 and be 396 bp in length. 
The green straight line represents the threshold value. The part of the score above the threshold suggests a possible presump-
tive promoter.BMC Biotechnology 2008, 8:28 http://www.biomedcentral.com/1472-6750/8/28
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TGEKP YKCPECGKSFSTSGELVRHQRTH
TGEKP YKCPECGKSFSRNDTLTEHQRTH
TGEKP YKCPECGKSFSRSDKLTEHQRTH
TGKKT S
Optimization of presumptive nucleotide sequence of ZFP
The presumptive nucleotide sequence (see Seq. 3) of the
ZFP was optimized at Graphical Codon Usage Analyser
[26].
5-ctggaaccgggtgaaa aaccttacaaatgtccgga atgtggtaaaagct-
tcagta cccacctggatctgatccgccaccagcgcactcaca ccggcgaaaaac-
cgtacaagtgcc cagaatgtggcaagagtttcagccacaccggccacc
tgctggaacatcagcgtacccataccggtgagaaaccgt acaaatgtcctgaat-
gcggcaaaagcttt agtcagcgcgcccacctggaacgccaccagcgtacccat
accggcgagaaaccgtataagtgtccggaatgcggcaagag
ctttagcaccagcggcgaactggtgcgccaccagcgcacccata
ccggtgaaaagccatataaatgcccggaatgcggtaaaagtttcagccgcaac
gataccctgaccgaacatcagcgtacccacaccggtgagaagccgtataaat-
gtcca gaatgtggtaagagttttagtcgcagcgataaactgaccgaacaccaacg-
cacccatacc ggtaaaaagaccagc-3 (528 bp)
ZFP sequence characterization and structural modeling
Analysis by PepTool Lite indicated that the 176-amino
acid sequence of the ZFP involves 6 regularly aligned, con-
tiguous Cys2His2-type zinc fingers, which show the typical
β-β-α secondary structure (Fig. 2A). ZFP characterization
using ExPASy Proteomics tools – ProtScale suggested that
the ZFP has a theoretical isoelectric point of 9.19 and a
molecular weight of 19.99 kDa [27,28]. Bulkiness analysis
indicated significant decreases in the scores of the dense
α-helix of each zinc finger in ZFP, and the scores of the
bulky β-fold were the highest [27]. Analysis of polarity
and accessible residues also confirmed that the con-
structed ZFP sequence possessed the structural character-
istics and possible biological activity of a typical zinc
finger. In the absence of Zn2+ (a stabilizer of the zinc finger
structure), the instability index of ZFP was calculated as
42.46, indicating structural instability. The theoretical
half-life of the ZFP was predicted to be 5.5 h in eukaryotic
cells but only 2 min in E. coli. Hence, if the ZFP is to be
expressed in prokaryotic cells, protease-deficient bacteria
should be used to decrease catabolism of the heterogene-
ous ZFP; moreover, Zn2+ should be added to the medium
to maintain the structural stability of the ZFP.
3-D structural modeling of the ZFP backbone was carried
out using the online Robetta server (Washington Univer-
sity)[29,30]. The ZFP file (in PDB format) sent via e-mail
was converted by RASWIN software to JPG format. The
image showed 6 contiguous zinc fingers, forming an
orderly helical structure (Fig. 2B).
Construction of pIRES2-EGFP/ZFP-flag recombinants
The insert DNA, a 573 bp fragment product amplified by
PCR, was subcloned into the plasmid vectors pIRES2-
EGFP after double digestion by the restriction endonucle-
ases XhoI and BamHI. The constructed recombinants
underwent restriction digest analysis with XhoI and the
A: Analysis by PepTool Lite indicated that the 176-amino acid sequence of the ZFP involves 6 regularly-aligned, contiguous  Cys2His2-type zinc fingers, which showed the typical β-β-α secondary structure Figure 2
A: Analysis by PepTool Lite indicated that the 176-amino acid sequence of the ZFP involves 6 regularly-
aligned, contiguous Cys2His2-type zinc fingers, which showed the typical β-β-α secondary structure.B: Illustra-
tion of 6 contiguous β-β-α zinc fingers constituted the 3-D structural modeling of the backbone of the ZFP, carried out on the 
online Robetta server. This orderly helical structure would be able to bind specially in the DNA major groove.BMC Biotechnology 2008, 8:28 http://www.biomedcentral.com/1472-6750/8/28
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digestion products were subjected to agarose gel electro-
phoresis; the result showed a clear electrophoretic band at
approximately 5.8 kb, consistent with the theoretical
results. Colony PCR analysis and the recombinant
sequencing results showed that the construction of
pIRES2-EGFP/ZFP-flag was successful.
Expression of green fluorescent protein by COS-7 cells
In the pIRES2-EGFP/ZFP-flag transfection group, cells
emitting green fluorescence were observed under the
microscope 12 h after transfection; 24 h after transfection
there were significantly more of these cells, up to dozens
in each visual field (100×), mostly emitting bright green
fluorescence. The fluorescence intensity reached a peak 48
h after transfection, and the cells were found to form
masses or pairs, with no significant differences between
the nuclear and cytoplasmic fluorescence intensities. In
order to determine the transfection efficiency, the cells
were counted in 10 random visual fields (100×) 36 h after
transfection. Of the 519 cells counted, 227 emitted green
fluorescence (43.7%). In the pIRES2-EGFP control group,
green fluorescence emitting cells were first observed 8 h
after transfection. Moreover, the number of cells emitting
green fluorescence and the fluorescence intensity were
higher in the pIRES2-EGFP control group than in the
pIRES2-EGFP/ZFP-flag transfection group at various times
of cell culture. In the control group, no green fluorescence
was observed (Fig. 3).
ZFP mRNA and protein were expressed significantly in 
COS-7 cells after transfected
Twenty-four hours after plasmid transfection, total RNA
was prepared from Cos7 cells. Electrophoresis showed
that the total RNA was not degraded. As expected, agarose
gel electrophoresis indicated a marked specific band at
392 bp after RT-PCR amplification, consistent with the
theoretical results (Fig. 4A). This result was not observed
in the pIRES2-EGFP control group. Forty-eight hours after
plasmid transfection, Western blotting showed obvious
protein bands in the pIRES2-EGFP/ZFP-flag transfection
group, but not in the pIRES2-EGFP control group, demon-
strating successful expression of the ZFP fusion Flag (Fig.
4B).
DNA binding activity
EMSA experiments showed corresponding lag bands in
the group of protein-specific probe binding reactions
(lanes 1 to 3), but no relevant band in the negative control
reaction array. In the Super-Shift reaction array, a lag band
of the "antigen-antibody-specific probe complex" was
Expression of green fluorescent protein in COS-7 cells transfected with recombinant plasmids pIRES2-EGFP/ZFP-flag seen  through the fluorescence microscope Figure 3
Expression of green fluorescent protein in COS-7 cells transfected with recombinant plasmids pIRES2-EGFP/
ZFP-flag seen through the fluorescence microscope. A: Expression 24 h after transfection (100×). B: Expression 36 h 
after transfection (200×). The result of the pIRES2-EGFP control group was omitted.BMC Biotechnology 2008, 8:28 http://www.biomedcentral.com/1472-6750/8/28
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observed (Fig. 4C). This experiment demonstrates that the
ZFP expressed by COS7 cells can bind to specific probes
and possesses biological activity and, at the same time,
has a correctly refolded 3-D structure. These findings pro-
vide clear evidence for the protein's ability to bind specif-
ically to the target DNA.
Discussion
With the rapid development of bioinformatics, the vol-
ume of biological information in various databases has
grown to huge proportions. Most of this information
could formerly be obtained only through laboratory
research. However, theoretically ideal biological informa-
tion can now be obtained through efficient use of bioin-
formatics tools [11]. This has allowed the research tools
for modern genetics, biology, biochemistry and pharma-
cology to expand [31-33].
These developments open new avenues in gene therapy by
designing proteins that do not exist naturally but can reg-
ulate specific genes by simulating the structure of a natu-
rally-occurring transcription factor. Gene expression is
regulated at the transcriptional level primarily (and most
economically and effectively) by transcription factors that
bind to DNA [3]. To intervene in gene expression, the pro-
moter of the gene of interest must first be studied. A gene
promoter contains a series of NA sequence elements
adjoining the transcriptional start site (TSS), which
A: RT-PCR was performed on total RNA isolated from COS7 cells transiently transfected for 24 h with pIRES2-EGFP/ZFP-flag Figure 4
A: RT-PCR was performed on total RNA isolated from COS7 cells transiently transfected for 24 h with 
pIRES2-EGFP/ZFP-flag. Agarose gel electrophoresis indicated an obvious specific amplification band at 392 bp. B: Western 
blotting. The pIRES2-EGFP/ZFP-flag transfection group showed clear protein bands 48 h after transfection, but these did not 
appear in the pIRES2-EGFP control group. C: Electrophoretic mobility shift assay. Lane 1: sample reaction array. Lane 2: "cold" 
competition assay of probes array. Lane 3: "cold" competition assay of mutated probes array. Lane 4: negative control reaction 
array. Lane 5: Super-Shift reaction array. A lag band of "antigen-antibody-specific probe complex" was observed (indicated by 
arrow).BMC Biotechnology 2008, 8:28 http://www.biomedcentral.com/1472-6750/8/28
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directly activate or inhibit transcription. Hence, the posi-
tion of a promoter can be located through the TSS, once
this has been identified. Therefore, precise location of the
TSS is the primary requirement for analyzing promoters
and transcriptional regulation. The promoter of a gene is
frequently located within 100 bp-300 bp upstream of the
TSS, and a typical core promoter includes a DNA sequence
covering about -40 bp-+50 bp of the TSS [34]. We defined
the A20 gene promoter and its TSS theoretically through
bioinformatics analysis and showed many potentially
important regulatory elements in the A20 promoter
region.
An ATF consists of a DNA-binding domain and a func-
tional domain [4-6]. The most crucial step in constructing
an effective ATF is to design the DNA-binding domain
successfully. Since Miller et al. found that the transcrip-
tion factor TFIIIA was a Cys2His2-type zinc finger protein
in Xenopus oocytes[35]; hundreds of proteins controlling
gene replication and transcription have been found con-
taining zinc finger motif. The Barbas Laboratory devel-
oped a series of artificial zinc finger domains by the phage
display technique, which recognized different members of
the 5'-NNN-3' family of DNA sequences (5'-GNN-3', 5'-
CNN-3', 5'-ANN-3', 5'-TNN-3') [9-11,36,37]. They also
used them to construct different ATFs. Thus, the Zinc Fin-
ger Tools identify individual zinc fingers as a module of
the protein's structural domain, and each of the contigu-
ous DNA triplets can specifically recognize an independ-
ent zinc finger module [12]. On this basis, as multiple
zinc finger modules are integrated into a segment of
polypeptide or protein sequence, the resulting sequence
can in theory bind a DNA sequence selectively. ZF Tools
greatly lower the workload of researchers studying ZFPs.
Since the working data of ZF Tools are the results of phage
display library screening, the results obtained are theoret-
ically credible; nevertheless, they have to be verified in the
laboratory.
Structural modeling of proteins by homologous sequence
comparison and alignment is relatively reliable. This
method is based on the principle that the 3-D structure of
a protein is more conserved than the primary struc-
ture[29]. Given this viewpoint, it is essential to acquire the
crystal structures of homologous proteins as template. In
fact, because of the increasing number of structural deter-
minations of ZFPs, homologous modeling of new pro-
teins containing zinc finger domains may be carried out.
We successfully obtained the PDB files of ZFPs from the
3D-JIGSAW, Swiss-Model and Robetta online servers.
Conclusion
It is feasible to design specific zinc finger proteins by bio-
informatics methods. This study provides a basis for arti-
ficially designing further complete transcription factors
and intervening in the expression of the A20 gene.
Methods
DNA synthesis
All the primers and the ZFP gene sequence subcloned in
the pUC19 plasmid were synthesized by Shanghai Sangon
Biological Engineering Technology & Services Co., Ltd.
Enzymes and reagents
PCR product purification kits were purchased from Bei-
jing Biodev-Tech, gel recovery kits and plasmid extraction
kits from Invitrogen, RT-PCR kits from Hangzhou Boer,
and nuclear and cytoplasmic protein extraction kits from
Beyotime. RPMI-1640 medium was purchased from
Gibco, fetal bovine serum from Hyclone, DOTAP lipo-
somes from Roche, Trizol reagent from Invitrogen, anti-
Flag antibody from the Antibody Research Center of
Shanghai Institutes for Biological Sciences, and HRP-
labeled secondary antibody from Santa Cruz. Taq DNA
polymerase and dNTPs were purchased from Promega,
restriction endonucleases, T4 DNA ligase and T4 polynu-
cleotide kinase from Takara, prestained standard protein
markers from MBI, ZnCl2, and nitrocellulose (NC) mem-
brane and X-ray film from Sigma.
Analysis of A20 gene promoter region
The A20 gene (GeneID:7128) and related sequences were
retrieved from the National Center for Biotechnology
Information[38]. The A20 gene promoter was analyzed
using the sequence processing tools TFSEARCH, TESS,
Gene2Promoter and McPromoter.
Design of presumptive nucleotide sequence of ZFP
We logged on to the Zinc Finger Tools server of the Barbas
Laboratory of the Scripps Research Institute, submitted
A20 promoter-related sequences, and set up parameters to
obtain the specific target site of the A20 gene promoter
region and the amino acid sequence of a ZFP. This amino
acid sequence was then reverse-translated into a nucleo-
tide sequence, and all codons in that sequence were opti-
mized. The full-length optimized sequence was sent to
Shanghai Sangon Company for full-gene synthesis.
ZFP sequence characterization and structural modeling
The characterization and structural analysis of the ZFP
were carried out using PepTool Lite 1.1 and ProtScale.
Homologous modeling of the ZFP tertiary structure was
conducted using Robetta.
Construction of pIRES2-EGFP/ZFP-flag eukaryotic 
expression plasmids
ZFP gene fragments were amplified by PCR, using pUC19-
ZFP as a template, and the primers were designed as fol-
lows. Forward: 5'-CCGCTCGAGATGGACTACAAGGAC-BMC Biotechnology 2008, 8:28 http://www.biomedcentral.com/1472-6750/8/28
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GACGATGACAAGCTGGAACCGGGTGA-3'; reverse: 5'-
CGGGGATCCGCTGGTCTTTTTACCGGTATGC-3'
(framed: restriction sites; underlined: Flag tag-encoding
sequence). PCR products and pIRES2-EGFP plasmids
were doubly-digested with the restriction endonucleases
XhoI and BamHI. According to the design protocol, T4
DNA ligase was used to ligate the target fragments, and the
ligated products were used to transform competent
TOP10 E. coli. The recombinants were preliminarily iden-
tified by restriction digest analysis and colony PCR (PCR
primers, forward: 5'-CCCAGAATGTGGCAAGAGTT-3',
reverse: 5'-TGCGTTGGTGTTCCGTCAGT-3'). The bacte-
rial suspensions containing positive recombinants were
sent to Shanghai Sangon Company for sequencing. The
recombinants identified were named pIRES2-EGFP/ZFP-
flag.
Transfection of COS-7 cells
COS-7 cells were routinely cultured in 24-well plates in
RPMI-1640 medium supplemented with 7% fetal bovine
serum, 0.1 mM (final concentration) ZnCl2 at 37°C and
6%CO2 in a humidified atmosphere. At 60% cell conflu-
ence, plasmid transfection was carried out according to
the instructions on the DOTAP kit. In the experimental
group, COS-7 cells were transfected with the recombinant
pIRES2-EGFP/ZFP-flag plasmids, and in the positive con-
trol group the cells were transfected with void pIRES2-
EGFP plasmids. In the blank group, liposomes instead of
plasmids were added.
Analysis of ZFP mRNA expression using RT-PCR
Cos7 cells were transfected for 24 h with the recombinant
pIRES2-EGFP/ZFP-flag plasmids. Total RNA was isolated
with Trizol Reagent (Invitrogen) according to the manu-
facturer's instructions. RNA purity was assessed by electro-
phoresis on formaldehyde-denaturing agarose gels and
measuring the OD260/OD280 absorption ratio. Five micro-
grams of total RNA was used to synthesize the first strand
cDNA under the conditions recommended by the manu-
facturer. Ten percent of the first strand cDNA was used as
template for the PCR. The primers used for RT-PCR ampli-
fication were the same as those used for colony PCR. The
amplified fragment should be 392 bp in length. PCR
amplification products were identified by 1.5% agarose
gel electrophoresis.
Analysis of ZFP protein expression using western blotting 
assay
Forty-eight hours after plasmid transfection, the cells were
collected and lyzed to extract total cellular protein. The
processed protein samples were subjected to SDS-polyacr-
ylamide gel electrophoresis and transferred on to a nitro-
cellulose membrane. The membrane was incubated
overnight with anti-Flag monoclonal antibody at 4°C and
with horseradish peroxidase (HRP)-labeled goat anti-
mouse secondary antibody at room temperature for 2 h.
Cells transfected with void pIRES2-EGFP plasmids were
used as control.
Electrophoretic mobility shift assay (EMSA)
On the basis of the target sequence selected from the A20
gene promoter region, a pair of specific probes was
designed as follows: ATCCCGGCCGGCTGGACGCACTT-
ACA, and a pair of mutated probes was also designed as
follows: ATCCTGGCCGGCTAGACGCACTTACA. The spe-
cific probes were labeled with [γ-32P]-ATP (3,000Ci/mmol
at 10mCi/ml) and purified. Forty-eight hours after plas-
mid transfection, cell protein was extracted. Electro-
phoretic mobility shift assays were conducted in
accordance with the protocol on the kit.
Abbreviations
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